down arrow

Gujarat Kidney

INR
157.75
4.4 (2.87%)
BSENSE

Aug 19, 11:21 AM

BSE+NSE Vol: 8.85 lacs

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationResults Declared: Gujarat Kidney has declared results on 14 Aug 2026! Click here to unlock the latest financial performance
stock-recommendationTechnical Trend Update: Gujarat Kidney witnessed a change in Technical Grade on 18 Aug 2026. Click here to discover latest technical change!
stock-recommendationMojo Score Change: Gujarat Kidney has changed its score on 18 Aug 2026. Click here to unlock latest mojo score!
stock-summaryPrice Point
High/Low

1Day

152.00161.10

52 Week

98.25161.10
Valuation
Technical
Day's Volume

CASH

8.85 lacs (-1.76%) Volume

Shareholding (Jun 2026)

FII

4.88%

Held by 12 FIIs

DII

0.56%

Held by 0 DIIs

Promoter

71.45%

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

19-Aug-2026

As of 18-Aug, Gujarat Kidney & Super Speciality Ltd's stock price is rising, currently at Rs. 152.90, with a notable increase of 14.53% over the last four days and a year-to-date gain of 48.81%. Strong investor interest, positive financial health, and significant delivery volume contribute to this upward trend.

As of 18-Aug, Gujarat Kidney & Super Speciality Ltd's stock price is rising, currently at Rs. 152.90, reflecting an increase of 1.8 (1.19%). The stock has shown significant positive momentum, having gained 14.53% over the last four days and outperforming its sector by 1.16% today. Notably, the stock reached a new 52-week and all-time high of Rs. 155, indicating strong investor interest.<BR><BR>The recent performance metrics further support this upward trend. Over the past week, the stock has increased by 14.32%, while the benchmark Sensex has declined by 1.18%. Similarly, in the past month, the stock rose by 18.94%, contrasting with a slight drop in the Sensex of 1.17%. Year-to-date, Gujarat Kidney & Super Speciality Ltd has achieved a remarkable 48.81% increase, while the Sensex has decreased by 9.37%.<BR><BR>Investor participation has also surged, with delivery volume on August 17 rising by 580.28% compared to the five-day average, indicating heightened interest and confidence among investors. Additionally, the stock is trading above its moving averages across various time frames, which is typically a bullish signal.<BR><BR>The company's financial health is another contributing factor to the stock's rise. It has a low Debt to EBITDA ratio of 1.08 times, indicating a strong ability to service its debt. The company has reported positive results in the last two consecutive quarters, with a notable growth in operating profit of 80.69% and net sales reaching their highest at Rs. 34.29 crore.<BR><BR>In summary, the combination of strong recent performance, increased investor participation, and positive financial indicators are driving the rise in Gujarat Kidney & Super Speciality Ltd's stock price.

View full answer

Which are the latest news on Gujarat Kidney?

19-Aug-2026
Broad-Based Technical Strength Lifts Gujarat Kidney & Super Speciality Ltd to 52-Week High of Rs 161.1
Strong Momentum Meets Stretched Valuations as Gujarat Kidney & Super Speciality Ltd Reaches All-Time High

Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

18-Aug-2026

What does Gujarat Kidney do?

14-Aug-2026

Gujarat Kidney & Super Speciality Ltd, a micro-cap company established in 2019, operates in the hospital industry and reported net sales of 31 Cr and a net profit of 5 Cr for the quarter ending March 2026. The company has a market cap of INR 1,054 Cr and key financial metrics include a P/E ratio of 69.00 and a return on equity of 6.14%.

Overview:<BR>Gujarat Kidney & Super Speciality Ltd operates in the hospital industry and is classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in 2019 under the name Vihaan Medicare Private Limited and later changed its name to Gujarat Kidney and Super Speciality Private Limited in September 2023. The most recent quarterly results report net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 31 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 5 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 1,054 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 69.00<BR>- Industry P/E: 67<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.11<BR>- Return on Equity: 6.14%<BR>- Price to Book: 4.16<BR><BR>Contact Details:<BR>Registrar Address: Not available.

View full answer

Who are the peers of the Gujarat Kidney?

14-Aug-2026

Peers of Gujarat Kidney include Dr Agarwal's Eye, KMC Speciality, Shalby, GPT Healthcare, Asarfi Hospital, Lotus Eye Hospital, Unihealth Hospital, Chandan Healthcare, and Aprameya Engineering. Asarfi Hospital has the highest 1-year return at 87.88%, while Shalby has the lowest at -24.54%.

Peers: The peers of Gujarat Kidney are Dr Agarwal's Eye, KMC Speciality, Shalby, GPT Healthcare, Asarfi Hospital, Lotus Eye Hospit, Unihealth Hosp, Chandan Healthca, and Aprameya Enginee.<BR><BR>Quality Snapshot: Excellent management risk is observed at KMC Speciality and GPT Healthcare, while Average management risk is found at Dr Agarwal's Eye, Asarfi Hospital, Unihealth Hosp, Chandan Healthca, and the rest. Below Average management risk is noted at Shalby and Lotus Eye Hospit. In terms of Growth, Excellent growth is seen at Unihealth Hosp and Chandan Healthca, Good growth at Dr Agarwal's Eye, KMC Speciality, Asarfi Hospital, and the rest, while Below Average growth is present at Shalby, GPT Healthcare, and Aprameya Enginee. For Capital Structure, Excellent capital structure is noted at KMC Speciality and GPT Healthcare, Good capital structure at Asarfi Hospital, Shalby, Lotus Eye Hospit, and Chandan Healthca, while Average capital structure is found at Dr Agarwal's Eye and the rest.<BR><BR>Return Snapshot: Asarfi Hospital has the highest 1-year return at 87.88%, while Shalby has the lowest at -24.54%. Gujarat Kidney's 1-year return is not available for comparison. Additionally, Shalby and GPT Healthcare have negative six-month returns.

View full answer

How big is Gujarat Kidney?

14-Aug-2026

As of 14th August, Gujarat Kidney & Super Speciality Ltd has a market capitalization of 1,077.79 Cr, with recent Net Sales of 82.02 Cr and a Net Profit of 15.49 Cr.

As of 14th August, Gujarat Kidney & Super Speciality Ltd has a market capitalization of 1,077.79 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Gujarat Kidney reported Net Sales of 82.02 Cr and a Net Profit of 15.49 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 25.94 Cr and Total Assets of 54.67 Cr.

View full answer

When is the next results date for Gujarat Kidney & Super Speciality Ltd?

07-Aug-2026

The next results date for Gujarat Kidney & Super Speciality Ltd is 14 August 2026.

The next results date for Gujarat Kidney & Super Speciality Ltd is scheduled for 14 August 2026.

View full answer

Compare Gujarat Kidney with Similar Stocks

GPT HealthcareUnihealth HospShalby
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.08 times

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%

 
3

With a growth in Operating Profit of 80.69%, the company declared Very Positive results in Jun 26

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 1,244 Cr (Micro Cap)

stock-summary
P/E

76.00

stock-summary
Industry P/E

67

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

6.14%

stock-summary
Price to Book

4.77

Revenue and Profits:
Net Sales:
34 Cr
(Quarterly Results - Jun 2026)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.05%
0%
10.05%
6 Months
43.21%
0%
43.21%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Gujarat Kidney for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Broad-Based Technical Strength Lifts Gujarat Kidney & Super Speciality Ltd to 52-Week High of Rs 161.1

Broad-Based Technical Strength Lifts Gujarat Kidney & Super Speciality Ltd to 52-Week High of Rs 161.1

Surging to an intraday peak of Rs 161.1 on 19 Aug 2026, Gujarat Kidney & Super Speciality Ltd has marked a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week.

Read full news article
Strong Momentum Meets Stretched Valuations as Gujarat Kidney & Super Speciality Ltd Reaches All-Time High

Strong Momentum Meets Stretched Valuations as Gujarat Kidney & Super Speciality Ltd Reaches All-Time High

Read full news article
Gujarat Kidney & Super Speciality Ltd Upgraded to Buy on Strong Technical and Financial Performance

Gujarat Kidney & Super Speciality Ltd Upgraded to Buy on Strong Technical and Financial Performance

Gujarat Kidney & Super Speciality Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 18 Aug 2026, is underpinned by robust quarterly results, bullish technical signals, and a favourable long-term growth outlook despite valuation concerns.

Read full news article

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

14-Aug-2026 | Source : BSE

Monitoring Agency Report June 2026

Board Meeting Outcome for Outcome Of Board Meeting

14-Aug-2026 | Source : BSE

Outcome of Board meeting for consideration of Unaudited financial results and other matters.

Statement Of Deviation & Variation As On June 30 2026

14-Aug-2026 | Source : BSE

Statement of Deviation & Variation as on June 30 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
12.54
Debt to EBITDA (avg)
0.92
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.74
Tax Ratio
20.82%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.44%
ROCE (avg)
26.45%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
76
Industry P/E
67
Price to Book Value
4.77
EV to EBIT
52.98
EV to EBITDA
43.74
EV to Capital Employed
5.23
EV to Sales
14.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.87%
ROE (Latest)
6.14%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
Bollinger Bands
Bullish
KST
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 12 FIIs (4.88%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Khandelwal Finance Private Limited (1.67%)

Individual Investors Holdings

10.64%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.00% vs -5.33% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 48.91% vs -41.20% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.24",
          "val2": "9.24",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.00",
          "val2": "1.57",
          "chgp": "91.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "0.50",
          "chgp": "-30.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.04",
          "val2": "1.37",
          "chgp": "48.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.47%",
          "val2": "16.99%",
          "chgp": "15.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.09",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.20",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.41%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.85",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.56",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.20%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.10",
          "val2": "35.17",
          "chgp": "14.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.14",
          "val2": "15.45",
          "chgp": "4.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "0.53",
          "chgp": "116.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.90",
          "val2": "9.11",
          "chgp": "8.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.25%",
          "val2": "43.93%",
          "chgp": "-3.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
9.24
9.24
Operating Profit (PBDIT) excl Other Income
3.00
1.57
91.08%
Interest
0.35
0.50
-30.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.04
1.37
48.91%
Operating Profit Margin (Excl OI)
32.47%
16.99%
15.48%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -5.33% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 48.91% vs -41.20% in Mar 2026

All Quarterly Resultsstock-summary

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Change(%)
Net Sales
21.09
NA
NA
Operating Profit (PBDIT) excl Other Income
10.42
NA
NA
Interest
0.36
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
6.20
NA
NA
Operating Profit Margin (Excl OI)
49.41%
NA%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Resultsstock-summary

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Change(%)
Net Sales
30.85
NA
NA
Operating Profit (PBDIT) excl Other Income
14.56
NA
NA
Interest
0.65
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
8.53
NA
NA
Operating Profit Margin (Excl OI)
47.20%
NA%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Resultsstock-summary

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
40.10
35.17
14.02%
Operating Profit (PBDIT) excl Other Income
16.14
15.45
4.47%
Interest
1.15
0.53
116.98%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.90
9.11
8.67%
Operating Profit Margin (Excl OI)
40.25%
43.93%
-3.68%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Resultsstock-summary
stock-summaryCompany CV
About Gujarat Kidney & Super Speciality Ltd stock-summary
stock-summary
Gujarat Kidney & Super Speciality Ltd
Micro Cap
Hospital
Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."